NASDAQ:NSTG NanoString Technologies Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NanoString Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $12.70 -0.02 (-0.16%) (As of 06/30/2022 12:00 AM ET) Add Compare Share Today's Range$12.19▼$12.7350-Day Range$12.29▼$20.4552-Week Range$11.81▼$65.39Volume1.40 million shsAverage Volume765,609 shsMarket Capitalization$589.48 millionP/E RatioN/ADividend YieldN/APrice Target$45.67 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive NSTG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NanoString Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address NSTG Stock Forecast (MarketRank)Overall MarketRank™1.87 out of 5 starsMedical Sector718th out of 1,433 stocksBiological Products, Except Diagnostic Industry114th out of 217 stocksAnalyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 - 3.5 Analyst's Opinion Consensus RatingNanoString Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $45.67, NanoString Technologies has a forecasted upside of 259.6% from its current price of $12.70.Amount of Analyst CoverageNanoString Technologies has only been the subject of 1 research reports in the past 90 days. Previous Next 4.4 Community Rank Outperform VotesNanoString Technologies has received 500 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNanoString Technologies has received 250 “underperform” votes. (Add your “underperform” vote.)Community SentimentNanoString Technologies has received 66.67% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about NanoString Technologies and other stocks. Vote “Outperform” if you believe NSTG will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NSTG will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldNanoString Technologies does not currently pay a dividend.Dividend GrowthNanoString Technologies does not have a long track record of dividend growth. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NanoString Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $24,137.00 in company stock.Percentage Held by InsidersOnly 2.80% of the stock of NanoString Technologies is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for NanoString Technologies are expected to grow in the coming year, from ($2.64) to ($2.07) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of NanoString Technologies is -4.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NanoString Technologies is -4.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNanoString Technologies has a P/B Ratio of 3.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About NanoString Technologies (NASDAQ:NSTG)NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.Read More NSTG Stock News HeadlinesJune 27, 2022 | finance.yahoo.comA Look At The Fair Value Of NanoString Technologies, Inc. (NASDAQ:NSTG)June 23, 2022 | americanbankingnews.comElisha W. Finney Sells 1,945 Shares of NanoString Technologies, Inc. (NASDAQ:NSTG) StockJune 15, 2022 | americanbankingnews.comNanoString Technologies (NASDAQ:NSTG) Sets New 1-Year Low at $13.46June 13, 2022 | benzinga.comNanoString Technologies Earnings Perspective: Return On Capital EmployedJune 12, 2022 | americanbankingnews.comBrokerages Set NanoString Technologies, Inc. (NASDAQ:NSTG) PT at $45.67June 6, 2022 | finance.yahoo.comNanoString Unveils AtoMx Spatial Informatics Portal at the 2022 Advances in Genome Biology and Technology (AGBT) General MeetingJune 5, 2022 | americanbankingnews.comNanoString Technologies (NASDAQ:NSTG) Shares Gap Down to $16.12June 4, 2022 | finance.yahoo.comIs Now An Opportune Moment To Examine NanoString Technologies, Inc. (NASDAQ:NSTG)?May 23, 2022 | finance.yahoo.comNanoString Launches Integrated Informatics to Facilitate Spatial Biology Research Using Next Generation SequencingMay 18, 2022 | finance.yahoo.comNanoString to Webcast Presentation from the UBS 2022 Global Healthcare ConferenceMay 12, 2022 | finance.yahoo.comFurther weakness as NanoString Technologies (NASDAQ:NSTG) drops 29% this week, taking one-year losses to 73%May 11, 2022 | markets.businessinsider.comWhat 4 Analyst Ratings Have To Say About NanoString TechnologiesMay 11, 2022 | seekingalpha.comNanoString Technologies, Inc. 2022 Q1 - Results - Earnings Call PresentationSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NSTG CUSIPN/A CIK1401708 Webwww.nanostring.com Phone(888) 358-6266Fax206-378-6288Employees766Year FoundedN/ACompany Calendar Last Earnings5/10/2022Today6/30/2022Next Earnings (Estimated)8/03/2022Fiscal Year End12/31/2022Price Target and Rating Average Stock Price Forecast$45.67 High Stock Price Forecast$70.00 Low Stock Price Forecast$30.00 Forecasted Upside/Downside+259.6%Consensus RatingBuy Rating Score (0-4)3 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($2.79) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-115.25 million Net Margins-87.89% Pretax Margin-87.76% Return on Equity-68.57% Return on Assets-26.32% Debt Debt-to-Equity Ratio1.55 Current Ratio7.81 Quick Ratio7.11 Sales & Book Value Annual Sales$145.09 million Price / Sales4.06 Cash FlowN/A Price / Cash FlowN/A Book Value$3.88 per share Price / Book3.27Miscellaneous Outstanding Shares46,416,000Free Float45,116,000Market Cap$589.48 million OptionableOptionable Beta1.99 NanoString Technologies Frequently Asked Questions Should I buy or sell NanoString Technologies stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoString Technologies in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" NanoString Technologies stock. View analyst ratings for NanoString Technologies or view top-rated stocks. What is NanoString Technologies' stock price forecast for 2022? 4 brokerages have issued twelve-month price objectives for NanoString Technologies' shares. Their NSTG stock forecasts range from $30.00 to $70.00. On average, they predict NanoString Technologies' stock price to reach $45.67 in the next year. This suggests a possible upside of 259.6% from the stock's current price. View analysts' price targets for NanoString Technologies or view top-rated stocks among Wall Street analysts. How has NanoString Technologies' stock price performed in 2022? NanoString Technologies' stock was trading at $42.23 at the beginning of the year. Since then, NSTG shares have decreased by 69.9% and is now trading at $12.70. View the best growth stocks for 2022 here. When is NanoString Technologies' next earnings date? NanoString Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022. View our earnings forecast for NanoString Technologies. How were NanoString Technologies' earnings last quarter? NanoString Technologies, Inc. (NASDAQ:NSTG) posted its quarterly earnings results on Tuesday, May, 10th. The biotechnology company reported ($0.86) earnings per share for the quarter, missing analysts' consensus estimates of ($0.54) by $0.32. The biotechnology company earned $31.08 million during the quarter, compared to the consensus estimate of $30.95 million. NanoString Technologies had a negative net margin of 87.89% and a negative trailing twelve-month return on equity of 68.57%. NanoString Technologies's revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter last year, the business posted ($0.62) earnings per share. View NanoString Technologies' earnings history. Who are NanoString Technologies' key executives? NanoString Technologies' management team includes the following people: Mr. R. Bradley Gray, CEO, Pres & Director (Age 45, Pay $1.12M) (LinkedIn Profile)Mr. K. Thomas Bailey M.B.A., Chief Financial Officer (Age 53, Pay $629.08k) (LinkedIn Profile)Dr. Joseph M. Beechem, Chief Scientific Officer and Sr. VP of R&D (Age 64, Pay $630.82k) (LinkedIn Profile)Mr. J. Chad Brown, Sr. Advisor (Age 64, Pay $599.59k)Mr. Mark A. Winham, Sr. VP of OperationsMr. Douglas S. Farrell, VP of Investor Relations & Corp. CommunicationsMs. Kathryn Surace-Smith, Sr. VP of HR & Legal Affairs and Corp. Sec. (Age 63)Mr. David W. Ghesquiere, Sr. VP of Corp. & Bus. Devel. (Age 55)Elizabeth Schneider Ph.D., Sr. Global Marketing Mang.Dr. Mary Tedd Allen, Sr. VP of Strategic Initiatives (Age 59) What is Brad Gray's approval rating as NanoString Technologies' CEO? 36 employees have rated NanoString Technologies CEO Brad Gray on Glassdoor.com. Brad Gray has an approval rating of 65% among NanoString Technologies' employees. Who are some of NanoString Technologies' key competitors? Some companies that are related to NanoString Technologies include Bavarian Nordic A/S (BVNRY), Twist Bioscience (TWST), BioCryst Pharmaceuticals (BCRX), Relay Therapeutics (RLAY), Iovance Biotherapeutics (IOVA), Krystal Biotech (KRYS), Allogene Therapeutics (ALLO), Immunocore (IMCR), ImmunityBio (IBRX), Revolution Medicines (RVMD), Recursion Pharmaceuticals (RXRX), Exscientia (EXAI), Vaxcyte (PCVX), Sana Biotechnology (SANA) and SpringWorks Therapeutics (SWTX). View all of NSTG's competitors. What other stocks do shareholders of NanoString Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other NanoString Technologies investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), Precision Drilling (PD), AutoZone (AZO), Designer Brands (DBI), Bank of the Ozarks (OZRK) and Vista Outdoor (VSTO). What is NanoString Technologies' stock symbol? NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG." How do I buy shares of NanoString Technologies? Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is NanoString Technologies' stock price today? One share of NSTG stock can currently be purchased for approximately $12.70. How much money does NanoString Technologies make? NanoString Technologies (NASDAQ:NSTG) has a market capitalization of $589.48 million and generates $145.09 million in revenue each year. The biotechnology company earns $-115.25 million in net income (profit) each year or ($2.79) on an earnings per share basis. How many employees does NanoString Technologies have? NanoString Technologies employs 766 workers across the globe. How can I contact NanoString Technologies? NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The official website for NanoString Technologies is www.nanostring.com. The biotechnology company can be reached via phone at (888) 358-6266, via email at [email protected], or via fax at 206-378-6288. This page (NASDAQ:NSTG) was last updated on 7/1/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
